Risk Stratification in Chronic Lymphocytic Leukemia
To access this article, please choose from the options below
Supported by Wilhelm Sander-Stiftung (2003.086.1, 2001.004.2), Deutsche Krebshilfe (106116, 70-3173-Tr 3 B4), Fresenius Stiftung (CLL4VH), Amgen, Roche, and Schering.
PII: S0093-7754(06)00026-1
doi:10.1053/j.seminoncol.2006.01.017
© 2006 Elsevier Inc. All rights reserved.
